Oct 30, 2026 08:40AM
Oct 20, 2026 08:12AM
Oct 20, 2026 08:12AM
Oct 16, 2026 09:20AM
Oct 16, 2026 09:20AM
Oct 7, 2026 08:45AM
Sep 29, 2026 08:45AM Moleculin completes Part A enrollment in AML trial, eyes Q1 2027 data
Sep 29, 2026 08:45AM
Sep 28, 2026 07:01AM
Sep 28, 2026 07:00AM
Sep 25, 2026 01:05PM
Sep 25, 2026 01:05PM
Sep 23, 2026 08:25AM
Sep 23, 2026 08:25AM Moleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040
Sep 14, 2026 08:35AM
Sep 11, 2026 08:30AM
Aug 27, 2026 09:01AM
Aug 14, 2026 08:30AM
Jul 31, 2026 10:12AM
Jul 31, 2026 10:12AM
Jul 31, 2026 08:10AM Moleculin reports 37% blinded remission rate in AML trial interim data
Jul 31, 2026 08:10AM
Jul 6, 2026 08:33AM
Jul 6, 2026 08:33AM
Jul 6, 2026 08:33AM
Jun 30, 2026 08:30AM
Jun 30, 2026 08:30AM
Jun 5, 2026 08:29AM Independent Market Research Finds Strong Physician Intent to Prescribe Moleculin's Annamycin in Relapsed/Refractory AML
Jun 5, 2026 08:29AM
Jun 4, 2026 08:31AM
May 29, 2026 08:21AM
May 21, 2026 05:02PM
May 21, 2026 05:02PM
May 15, 2026 08:30AM
May 13, 2026 08:03AM Moleculin nears data unblinding for leukemia drug trial
May 13, 2026 08:00AM
May 12, 2026 09:30AM
May 12, 2026 09:30AM
May 12, 2026 09:30AM
May 8, 2026 08:45AM
May 8, 2026 08:45AM
Apr 23, 2026 08:27AM Moleculin's Annamycin shows promise in pancreatic cancer preclinical study
Apr 23, 2026 08:25AM
Apr 21, 2026 08:36AM
Apr 7, 2026 12:52PM
Apr 7, 2026 08:42AM
Apr 7, 2026 08:36AM
Apr 7, 2026 08:36AM
Mar 23, 2026 08:33AM Moleculin reaches 45-patient milestone in pivotal leukemia trial
Mar 23, 2026 08:31AM

336,254 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All